We are monitoring the impact of COVID-19 on Asia Pacific Ureteral Stents Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5343
Share on
Share on

Asia Pacific Ureteral Stents Market Research Report - Segmented By Type, Patients Sex, End User, Medical Situation & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Size, Share, Trends, Growth, Forecast | 2021 to 2026

Pulished: April, 2021
ID: 5343
Pages: 145

Asia Pacific Ureteral Stents Market Size & Growth (2021 to 2026):

The Size of the ureteral Stents Market in the Asia Pacific was valued at USD 84.67 Million in 2021 and is poised to reach USD 131.37 Million by 2026, to grow at a CAGR of 9.18% during the forecast period 2021 to 2026.

Due to the rising prevalence of urological disorders, government measures to strengthen the healthcare system, and increased disposable money among the middle-class population, Asia Pacific offers significant potential. A ureteral stent is a small hollow tube put into the ureter to relieve blockages in the urine flow of the kidney. Urolithiasis (kidney and ureteral stones) and urine incontinence are becoming more common around the region due to many reasons, such as increased calcium in the diet, alcohol consumption, and unhealthy lifestyles.

Ureteroscopy and ureterorenoscopy, among other things, need a ureteral stent to treat kidney stones, which is driving the market. Negative lifestyle behaviors such as alcohol consumption and an increase in the number of smokers and an obese population with dietary abnormalities are a few of the variables that contribute to such disorders or conditions. After the kidney transplant, a ureteral stent is implanted in the patient's body for a few days to allow the newly transplanted kidney to acclimatize to the patient's body.

The demand for ureteral stents has increased due to the rising number of kidney transplants and issues with renal dysfunction. It is expected to fuel the market for ureteral stents during the next few years. Furthermore, increased kidney transplants, the geriatric population, and developments in stent composition materials are projected to drive market growth. Due to a higher frequency of urinary tract infections and higher adoption of ureteral stents, the urinary tract infection segment is expected to grow significantly in the ureteral stents market.

The market's expansion is restricted by a shortage of experienced specialists and the adverse side effects connected with the usage of ureteral stents.

This research report on the Asia Pacific Ureteral Stents Market has been segmented and sub-segmented into the following categories

By Type:

  • Expandable Stent
  • Double pigtail stent (JJ Stent))

By Patients Sex:

  • Male
  • Female

By End User:

  • Hospital
  • Clinical

By Medical Situation:

  • Kidney Stones
  • Kidney Failures
  • Tumors

By Country:

  • India
  • China
  • Japan,
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, Asia Pacific is expected to have the highest CAGR among others. A high aging population with kidney-related disorders, increased urological procedures, and improving healthcare infrastructure in this nation are all driving the market. Furthermore, the expanding medical tourism industry in developing countries such as India, China, and Japan is expected to boost market growth.

In addition, increased government healthcare spending, increased number of hospitalizations, enhanced reimbursement scenarios, and low ureteral stent manufacturing costs are a few other factors supporting the market's expansion in this area. Furthermore, factors driving the adoption of ureteral stents technology include an increase in the incidence of urological diseases caused by microorganism colonization or a sedentary lifestyle, an increase in the geriatric population, and technological advancements in stent composition materials.

In addition, more effective and better outcomes for urinary and renal problems have resulted from technological developments in ureteral stents due to biodegradable polymers. Furthermore, throughout the operation, leading companies are focused on lowering stent migration, ureterovesical reflux, and tissue irritation, which is expected to boost the market growth.

KEY MARKET PLAYERS

Top Companies leading the Asia Pacific Ureteral Stents Market Profiled in the Report are UteraC. R. Bard, Inc., Penn Medical, Cook Medical Inc., Boston Scientific Corporation and Medline Industries, Inc.,

1. Introduction       

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                 

                2.1 Introduction     

                2.2 Research Phases                      

      2.2.1 Secondary Research           

      2.2.2 Primary Research 

      2.2.3 Econometric Modelling      

      2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline

3. Overview             

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)          

                4.1 Market Drivers

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market    

5. Market Segmentation                    

                5.1 Patient's Sex    

      5.1.1 Introduction           

      5.1.2 Female     

      5.1.3 Male          

      5.1.4  Y-o-Y Growth Analysis, By Patient's Sex    

      5.1.5  Market Attractiveness Analysis, By Patient's Sex  

      5.1.6  Market Share Analysis, By Patient's Sex    

                5.2 Type    

      5.2.1 Introduction           

      5.2.2 Expandable Stent 

      5.2.3 Double pigtail stent (JJ Stent)         

      5.2.4 Others      

      5.2.5 Y-o-Y Growth Analysis, By Type     

      5.2.6 Market Attractiveness Analysis, By Type   

      5.2.7 Market Share Analysis, By Type     

                5.3 Medical Situation                     

      5.3.1 Introduction           

      5.3.2 Kidney Failure        

      5.3.3 Kidney Stones       

                      5.3.3.1 Ureteroscopy

                      5.3.3.2 Ureteroenoscopy

      5.3.4 Tumors     

      5.3.5 Others      

      5.3.6 Y-o-Y Growth Analysis, By Medical Situation            

      5.3.7  Market Attractiveness Analysis, By Medical Situation         

      5.3.8  Market Share Analysis, By Medical Situation           

                5.4 End-User                      

      5.4.1 Introduction           

      5.4.2 Hospital    

      5.4.3 Clinical       

      5.4.4 Y-o-Y Growth Analysis, By End User             

      5.4.5  Market Attractiveness Analysis, By End User          

      5.4.5  Market Share Analysis, By End User            

6. Geographical Analysis                    

                6.1 Introduction     

      6.1.1 Regional Trends    

      6.1.2 Impact Analysis     

      6.1.3 Y-o-Y Growth Analysis        

                      6.1.3.1 By Geographical Area

                      6.1.3.2 By Patient's Sex

                      6.1.3.3 By Type

                      6.1.3.4 By Medical Situation

                      6.1.3.5 By End User

      6.1.4  Market Attractiveness Analysis     

                      6.1.4.1 By Geographical Area

                      6.1.4.2 By Patient's Sex

                      6.1.4.3 By Type

                      6.1.4.4 By Medical Situation

                      6.1.4.5 By End User

      6.1.5  Market Share Analysis      

                      6.1.5.1 By Geographical Area

                      6.1.5.2 By Patient's Sex

                      6.1.5.3 By Type

                      6.1.5.4 By Medical Situation

                      6.1.5.5 By End User

                6.2 China   

                6.3 India    

                6.4 Japan  

                6.5 South Korea     

                6.6 Australia         

                6.7 Rest of APAC             

7. Strategic Analysis             

                7.1 PESTLE analysis                         

      7.1.1 Political     

      7.1.2 Economic 

      7.1.3 Social         

      7.1.4 Technological         

      7.1.5 Legal          

      7.1.6 Environmental       

                7.2 Porter’s Five analysis    

      7.2.1 Bargaining Power of Suppliers        

      7.2.2 Bargaining Power of Consumers    

      7.2.3 Threat of New Entrants     

      7.2.4 Threat of Substitute Products and Services              

      7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis              

                8.1 Boston Scientific Corporation   

      8.1.1 Overview 

      8.1.2 Product Analysis   

      8.1.3 Financial analysis  

      8.1.4 Recent Developments       

      8.1.5 SWOT analysis       

      8.1.6 Analyst View          

                8.2 Cook Medical Inc.                    

                8.3 C. R. Bard, Inc. 

                8.4 Medline Industries, Inc.                        

                8.5 Pnn Medical     

9. Competitive Landscape                 

                9.1 Market share analysis  

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities               

Appendix                 

                a) List of Tables                

                b) List of Figures    

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms product type and Packaged Containers along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Ureteral Stents Market By Type, From 2021 to 2026 ( USD Million )
  2. Asia Pacific Expandable Stent Market By Region, From 2021 to 2026 ( USD Million )
  3. Asia Pacific Double pigtail stent (JJ Stent) Market By Region, From 2021 to 2026 ( USD Million )
  4. Asia Pacific Others Market By Region, From 2021 to 2026 ( USD Million )
  5. Asia Pacific Ureteral Stents Market By End Use, From 2021 to 2026 ( USD Million )
  6. Asia Pacific Hospital Market By Region, From 2021 to 2026 ( USD Million )
  7. Asia Pacific Clinical Market By Region, From 2021 to 2026 ( USD Million )
  8. Asia Pacific Ureteral Stents Market By patients sex, From 2021 to 2026 ( USD Million )
  9. Asia Pacific Female Market By Region, From 2021 to 2026 ( USD Million )
  10. Asia Pacific Male Market By Region, From 2021 to 2026 ( USD Million )
  11. Asia Pacific Ureteral Stents Market By Medical situation, From 2021 to 2026 ( USD Million )
  12. Asia Pacific Kidney Failure Market By Region, From 2021 to 2026 ( USD Million )
  13. Asia Pacific Kidney Stones Market By Region, From 2021 to 2026 ( USD Million )
  14. Asia Pacific Tumors Market By Region, From 2021 to 2026 ( USD Million )
  15. Asia Pacific Others Market By Region, From 2021 to 2026 ( USD Million )
  16. Japan Ureteral Stents Market By Type, From 2021 to 2026 ( USD Million )
  17. Japan Ureteral Stents Market By End Use, From 2021 to 2026 ( USD Million )
  18. Japan Ureteral Stents Market By patients sex, From 2021 to 2026 ( USD Million )
  19. Japan Ureteral Stents Market By Medical situation, From 2021 to 2026 ( USD Million )
  20. China Ureteral Stents Market By Type, From 2021 to 2026 ( USD Million )
  21. China Ureteral Stents Market By End Use, From 2021 to 2026 ( USD Million )
  22. China Ureteral Stents Market By patients sex, From 2021 to 2026 ( USD Million )
  23. China Ureteral Stents Market By Medical situation, From 2021 to 2026 ( USD Million )
  24. India Ureteral Stents Market By Type, From 2021 to 2026 ( USD Million )
  25. India Ureteral Stents Market By End Use, From 2021 to 2026 ( USD Million )
  26. India Ureteral Stents Market By patients sex, From 2021 to 2026 ( USD Million )
  27. India Ureteral Stents Market By Medical situation, From 2021 to 2026 ( USD Million )
  28. Australia Ureteral Stents Market By Type, From 2021 to 2026 ( USD Million )
  29. Australia Ureteral Stents Market By End Use, From 2021 to 2026 ( USD Million )
  30. Australia Ureteral Stents Market By patients sex, From 2021 to 2026 ( USD Million )
  31. Australia Ureteral Stents Market By Medical situation, From 2021 to 2026 ( USD Million )
  32. South Korea Ureteral Stents Market By Type, From 2021 to 2026 ( USD Million )
  33. South Korea Ureteral Stents Market By End Use, From 2021 to 2026 ( USD Million )
  34. South Korea Ureteral Stents Market By patients sex, From 2021 to 2026 ( USD Million )
  35. South Korea Ureteral Stents Market By Medical situation, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample